Company Profile (AI Text)
Name: NEXTLEAP Cold Sore Care
Canonical URL: https://wefunder.com/NEXTLEAP
Updated at: 2026-06-08T05:01:30Z

Tagline: A new breakthrough treatment approach for cold sores-Return to Normal in 1-2 Days!

Key claims:
- Total raised on Wefunder: 106550 | citation: https://wefunder.com/NEXTLEAP#claim-total-raised
- Total investors: 25 | citation: https://wefunder.com/NEXTLEAP#claim-total-investors

Verified facts:
- Total raised on Wefunder: 106550 | observed_at: 2026-06-08T05:01:30Z | expires_at: 2026-06-09T05:01:30Z
- Total investors: 25 | observed_at: 2026-06-08T05:01:30Z | expires_at: 2026-06-09T05:01:30Z

Computed metrics:
- total_amount_raised: 106550
- total_investors: 25
- team_size: 2
- featured_investor_count: 1
- faq_count: 3
- recent_post_count: 0

Quick facts:
- The cold sore market is very large but remains underserved. | citation: https://wefunder.com/NEXTLEAP#claim-fact-1
- Our novel and IP protected (via license) product provides new and improved results to customers. | citation: https://wefunder.com/NEXTLEAP#claim-fact-2
- Established with the leading online marketplaces and poised for rapid growth with added resources. | citation: https://wefunder.com/NEXTLEAP#claim-fact-3
- Continuous improvement in online marketing tools including addition of social media influencers | citation: https://wefunder.com/NEXTLEAP#claim-fact-4
- Monthly sales growth of 300% over the last year and accelerating | citation: https://wefunder.com/NEXTLEAP#claim-fact-5
- Hitting sales targets with repeat and new customers as expected | citation: https://wefunder.com/NEXTLEAP#claim-fact-6

FAQ:
- Q: How does this compare to valaciclovir? My understanding was that this existing treatment could get rid of cold sores within 1-2 days for most people.
  A: Michael, thanks for your question and your interest in NextLeap. From our research, the best answer to your question comes from the package insert for Valtrex (brand name for valaciclovir), which you can find online under Highlights of Prescribing Information Valtrex in accessdata.fda.gov. Section 14.1 discusses the clinical studies using Valtrex against cold sores. It states: "Subjects self-initiated therapy at the earliest symptoms and prior to any signs of a cold sore.” The results: "The m...
- Q: What was your revenue for 2023, 2023 profit / loss (unaudited is understood), how long is your current runway, and what do you anticipate will be needed to hit profitability? Thank you!
  A: Hello Jason, thanks for reaching out. At the end of 2023 we were burning about $6k per month and had a runway of approx 18 months at that rate. Plans are to hit profitability in approximately 9 months.
- Q: Could you explain the differences between your product and your competitors? Also, what happens if you go out of business?
  A: Thank you for the question Charles. We are approaching an outbreak in a new way by helping to minimize the disruption to a person’s appearance during an outbreak. And we do it with a clear and odorless gel. Other products can act as temporary pain relievers, cosmetic cover-ups or attempt to speed up healing but there is a gap where a cold sore sufferer has to deal with the physical and by extension the emotional impact of an outbreak on their self confidence and social plans. NEXTLEAP is desi...